eGene Overview

  • Founded
  • 2000
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 2

eGene General Information

Description

Developer of bio-separation and detection tools. The company provider of sample and assay technologies for research in life sciences, applied testing and molecular diagnostics. It specializes in electrophoresis, microfluidics, liquid handling and automation genotyping DNA testing tools for the biological, microbial materials and life sciences testing industries. Its DNA HDA-GT12 system detects, quantifies, identifies and characterizes biological organisms and automates routine and non-routine laboratory and industrial procedures critical to productivity.

Contact Information

Formerly Known As
BioCal Technology
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Discovery Tools (Healthcare)
Drug Discovery
Acquirer
Primary Office
  • 17841 Fitch
  • Irvine, CA 92614
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

eGene Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore eGene‘s full profile, request access.

Request a free trial

eGene Executive Team (2)

Name Title Board Seat Contact Info
Ming-Sun Liu Ph.D Chairman, President & Chief Executive Officer
Udo Henseler Chief Executive Officer
To view eGene’s complete executive team members history, request access »